|
Volumn 42, Issue 1086, 2000, Pages 80-81
|
A new long-acting methylphenidate (Concerta)
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHETAMINE;
DEXAMPHETAMINE;
DEXEDRINE SPANSULE;
METHYLIN ER;
METHYLPHENIDATE;
PEMOLINE;
PEMOLINE MAGNESIUM;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ANOREXIA;
ATTENTION DEFICIT DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
HEADACHE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INSOMNIA;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
OSMOTIC PUMP;
PRESCHOOL CHILD;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
SHORT SURVEY;
SUSTAINED RELEASE PREPARATION;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CHILD;
CLINICAL TRIALS;
DELAYED-ACTION PREPARATIONS;
DEXTROAMPHETAMINE;
FEES, PHARMACEUTICAL;
HALF-LIFE;
HUMANS;
METHYLPHENIDATE;
TIME FACTORS;
|
EID: 0034604917
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (0)
|